QuotedData’s morning briefing 1 November 2024 – BPCR, RNEW
In QuotedData’s morning briefing 1 November:
- BioPharma Credit (BPCR) announced that it has made an additional investment in Insmed Incorporated following its initial loan made in October 2022. The company is investing US$60m in a new US$150m, with BioPharma-V investing US$90m. Together with the accrual and capitalization of the partial paid-in-kind interest, the company’s total exposure to Insmed will be approximately US$223.5m. Based in the US, Insmed is a publicly traded biopharmaceutical company with a current market capitalization of ~US$12 bn (Ticker: INSM – NASDAQ). Insmed is a commercial stage global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. It recently reported trailing nine-month net sales of US$259m during the period ending 30 September 2024.
- Ecofin US Renewables Infrastructure trust (RNEW) announced that director Louisa Vincent has stepped down from the board with effect from today’s date.
Investment company news brought to you by QuotedData by Marten & Co.
